BioMérieux this week appointed of two new independent directors, Agnès Lemarchand and Philippe Gillet. Lemarchand and Gillet are replacing Georges Hibon and Michel Angé, who did not wish to renew their terms on the company's board.
Lemarchand has served as CEO of Industrie Biologique Française, a joint venture between the Rhône-Poulenc group and Institut Mérieux. She has also served as chairman and CEO of Prodical, a subsidiary of the Ciments Français group; and chairman and CEO of the Lafarge group's lime business.
Gillet was a professor of geophysics at the University of Rennes prior to becoming director of l’Ecole Normale Supérieure de Lyon, where he was also a professor of earth sciences. In addition, from May 2007 to April 2010 he served as chief of staff for the French Minister of Higher Education and Research. He subsequently joined l’Ecole Polytechnique Fédérale of Lausanne, where he serves as vice president for academic affairs.
Exosome Diagnostics has named William Kelly as CFO.
Kelly has worked for RepliGen for the past six years, serving as the principal financial officer there for more than five years. He has also served as corporate controller of Haemonetics, and has worked for Deloitte & Touche.